- Patent Title: Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
-
Application No.: US15702427Application Date: 2017-09-12
-
Publication No.: US10647696B2Publication Date: 2020-05-12
- Inventor: Manmohan Reddy Leleti , Yandong Li , Venkat Reddy Mali , Jay Powers , Ju Yang
- Applicant: CHEMOCENTRYX, INC.
- Applicant Address: US CA Mountain View
- Assignee: ChemoCentryx, Inc.
- Current Assignee: ChemoCentryx, Inc.
- Current Assignee Address: US CA Mountain View
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo PC
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D401/10 ; C07D403/12 ; C07D405/14 ; C07D403/04 ; C07D403/14 ; C07D235/06
Abstract:
Benzimidazole, benzopyrazole and benzotriazole compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft rejection and cancer.
Public/Granted literature
- US20180127395A1 SUBSTITUTED BENZIMIDAZOLES AND BENZOPYRAZOLES AS CCR(4) ANTAGONISTS Public/Granted day:2018-05-10
Information query
